Highlights
- Sales over the Year and quarter: The company’s sales declined by -14.71 % over the year, substantial increase in net sales/revenue by 51.49 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -82.33 %, Marginal decrease of -41.03% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for JHS Svendgaard Laboratories Limited. Profit dropped by -92.58 % Year to Year, JHS Svendgaard Laboratories Limited’s profitability dropped by -5884.62 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -93.42 % Year to Year.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 25.399 Cr | Rs. 14.3 Cr | Rs. 21.663 Cr | + 51.49 % | -14.71 % |
| Expenses | Rs. 28.25 Cr | Rs. 14.36 Cr | Rs. 20.83 Cr | + 45.06 % | -26.27 % |
| Operating Profit | Rs. -2.85 Cr | Rs. -0.06 Cr | Rs. 0.83 Cr | + 1483.33 % | + 129.12 % |
| OPM % | -11.22 % | -0.42 % | 3.83 % | + 4.25 % | + 15.05 % |
| Other Income | Rs. 7.81 Cr | Rs. 2.34 Cr | Rs. 1.38 Cr | -41.03 % | -82.33 % |
| Interest | Rs. 0.39 Cr | Rs. 0.11 Cr | Rs. 0.13 Cr | + 18.18 % | -66.67 % |
| Depreciation | Rs. 2.31 Cr | Rs. 1.63 Cr | Rs. 1.9 Cr | + 16.56 % | -17.75 % |
| Profit before tax | Rs. 2.26 Cr | Rs. 0.54 Cr | Rs. 0.18 Cr | -66.67 % | -92.04 % |
| Tax % | -38.14 % | 97.64 % | 520.11 % | + 422.47 % | + 558.25 % |
| Net Profit | Rs. -10.13 Cr | Rs. 0.01 Cr | Rs. -0.75 Cr | -7600 % | + 92.6 % |
| EPS in Rs | Rs. -1.52 | Rs. 0 | Rs. -0.1 | 0 % | + 93.42 % |
Today, we’re looking at JHS Svendgaard Laboratories Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -14.71 %. However, it did see a marginal increase of 51.49 % from the previous quarter. Expenses ticked up slightly by 45.06 % quarter-on-quarter, aligning with the annual decline of -26.27 %. Operating profit, while up 129.12 % compared to last year, faced a quarter-on-quarter increase of 1483.33 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 15.05 %, but an expansion of 4.25 % sequentially. Other income fell by -41.03 % compared to the last quarter, despite an annual decline of -82.33 %. Interest expenses surged remarkably by 18.18 % from the previous quarter, yet the year-over-year decrease remains at a moderate -66.67 %. Depreciation costs climbed by 16.56 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -17.75 %. Profit before tax declined annually by -92.04 % but saw a reduction from the preceding quarter by -66.67 %.
Tax expenses as a percentage of profits increased slightly by 558.25 % compared to last year, with a more notable quarter-on-quarter increase of 422.47 %. Net profit rose by 92.6 % year-on-year but witnessed a -7600 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 93.42 % In summary, JHS Svendgaard Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 25.399 Cr | Rs. 14.3 Cr | Rs. 21.663 Cr | + 51.49 % | -14.71 % |
| Expenses | Rs. 28.25 Cr | Rs. 14.36 Cr | Rs. 20.83 Cr | + 45.06 % | -26.27 % |
| Operating Profit | Rs. -2.85 Cr | Rs. -0.06 Cr | Rs. 0.83 Cr | + 1483.33 % | + 129.12 % |
| Net Profit | Rs. -10.13 Cr | Rs. 0.01 Cr | Rs. -0.75 Cr | -7600 % | + 92.6 % |
| EPS in Rs | Rs. -1.52 | Rs. 0 | Rs. -0.1 | 0 % | + 93.42 % |
In reviewing JHS Svendgaard Laboratories Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -14.71 % year-on-year, however, there was a minor increase of 51.49 % from the previous quarter. Expenses decreased by -26.27 % compared to the previous year, with a 45.06 % increase quarter-on-quarter. Operating Profit surged by 129.12 % annually, and saw a 1483.33 % increase from the last quarter.
Net Profit showed yearly increase of 92.6 %, and experienced a -7600 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 93.42 % annually, In essence, while JHS Svendgaard Laboratories Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
